Therapeutic targeting of Respiratory Syncytial Virus: Current pharmacological options and future directions in antiviral development
{{output}}
Respiratory syncytial virus (RSV) remains a major cause of severe acute respiratory infections across the life course, particularly in infants, older adults, and immunocompromised individuals. For decades, clinical management relied almost exclusively on suppo... ...
